Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
ORAGENICS INC (OGEN)
|
Add to portfolio |
|
|
|
| Price: |
$0.56
| | Metrics |
| OS: |
2.54
|
M
| |
|
|
| Market cap: |
$1.42
|
M
| |
|
|
|
Net cash:
|
$6.47
|
M
| |
$2.55
|
per share
|
|
EV:
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 |
| Revenue growth | | | | | | | -100.0% | -8.9% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -10.0 | 0.0 | 0.4 |
| Gross profit | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 10.0 | 0.0 | 0.6 |
| Gross margin | 100.0% | | | | | | | 60.7% |
| Selling, general and administrative | | | | | | | | 3.3 |
| Research and development | 10.6 | 22.1 | 12.1 | 6.0 | 3.5 | 4.8 | 8.7 | 3.1 |
| General and administrative | 5.3 | 4.5 | 3.8 | 4.0 | 3.2 | 3.8 | 3.0 | |
| EBIT | -15.8 | -26.6 | -15.9 | -10.0 | -6.7 | -7.1 | -11.8 | -5.8 |
| EBIT margin | -18130.3% | | | | | | | -618.8% |
| Pre-tax income | -15.7 | -26.4 | -15.6 | -9.9 | -6.7 | -8.5 | -11.8 | -5.8 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -15.7 | -26.4 | -15.6 | -11.3 | -6.7 | -7.0 | -11.7 | -5.8 |
| Net margin | -18062.0% | | | | | | | -616.0% |
| |
| Diluted EPS | ($0.14) | ($0.47) | ($0.37) | ($0.87) | ($1.37) | ($1.90) | ($0.32) | ($0.16) |
| Shares outstanding (diluted) | 112.9 | 56.5 | 42.3 | 13.0 | 4.9 | 4.5 | 36.7 | 36.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|